| Name | Title | Contact Details |
|---|
Brahms USA, LLC is a Annapolis, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Inland Imaging Svc is a Grand Terrace, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
C-TASC provides products and services to support responsible management of clinical trials, clinical surveys, case/control studies, clinical registries, clinical cohort studies and laboratory studies. For over 15 years C-TASC's services group has played nearly every role in studies of all sizes. Our experienced and professional medical and biostatistical staff can provide expertise in complete study design, data collection and management and data analysis. C-TASC's software group has developed, hosted and managed Web-based clinical data management systems for dozens of studies including the recent release of our SaaS product StudyCTMS.com, an end-to-end clinical trials management system (CTMS) including electronic data capture (EDC), integrated SAS, a drag and drop form builder and many other intuitive tools. StudyCTMS.com is an affordable solution for every investigator. Our location is convenient to Washington DC, Maryland, Philadelphia, and Southern New Jersey.
Pacific Pulmonary Services is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Novato, CA. To find more information about Pacific Pulmonary Services, please visit www.ppsc.com
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.